TrialESMO open2021

Impact of age and gender on the efficacy and safety of upfront therapy with panitumumab plus FOLFOX followed by panitumumab-based maintenance: a pre-specified subgroup analysis of the Valentino study.

A Raimondi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.